UBS Group
GNVC

UBS Group’s GenVec, Inc. GNVC Stock Holding History

UBS Group’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-370
Closed -$2K – 8485
2017
Q1 		$2K Hold
370
– – ﹤0.01% 7385
2016
Q4 		$1K Sell
370
-481
-57% -$1.67K ﹤0.01% 7722
2016
Q3 		$4K Buy
851
+346
+69% +$2K ﹤0.01% 7261
2016
Q2 		$3K Sell
505
-605
-55% -$4.23K ﹤0.01% 7408
2016
Q1 		$9K Buy
1,110
+605
+120% +$4.05K ﹤0.01% 6770
2015
Q4 		$9K Sell
505
-310
-38% -$5.92K ﹤0.01% 7411
2015
Q3 		$19K Buy
815
+122
+18% +$2.91K ﹤0.01% 6787
2015
Q2 		$14K Buy
693
+228
+49% +$5.56K ﹤0.01% 7236
2015
Q1 		$14K Sell
465
-98
-17% -$3.22K ﹤0.01% 7410
2014
Q4 		$12K Buy
+563
New +$10.9K ﹤0.01% 8286

UBS Group's GNVC Position: Q2 2017 in Review

UBS Group sold out of GenVec, Inc. (GNVC) in Q2 2017, closing a stake of 370 shares — an estimated $2K sold.

UBS Group first reported a position in GNVC in Q4 2014 and held it in 10 quarters. The position peaked at $19K in Q3 2015. 0 funds tracked by Wall St. Rank hold GNVC as of Q2 2017.

  • UBS Group reported no remaining GenVec, Inc. position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 370 GenVec, Inc. shares in Q2 2017, an estimated $2K.
  • UBS Group first reported a position in GenVec, Inc. in Q4 2014 and held it in 10 quarters.
  • UBS Group's GenVec, Inc. position peaked at $19K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.